Yeşilyurt Dirican, Z. E. Et Al. 2023. Investigating the effects of empagliflozin and linagliptin treatment on the heart of STZ-diabetic rats: Do they affect cardiac miRNAs?. The CVOT Summit 2023 , (Munich, Germany), 18-19.

Yeşilyurt Dirican, Z. E., Tokcaer Keskin, Z., Çelik, D., Peker, E. B., Küçükyıldız, K., Dalar, S. F., ... Michel, M. C.(2023). Investigating the effects of empagliflozin and linagliptin treatment on the heart of STZ-diabetic rats: Do they affect cardiac miRNAs? . The CVOT Summit 2023 (pp.18-19). Munich, Germany

Yeşilyurt Dirican, ZEYNEP Et Al. "Investigating the effects of empagliflozin and linagliptin treatment on the heart of STZ-diabetic rats: Do they affect cardiac miRNAs?," The CVOT Summit 2023 , Munich, Germany, 2023

Yeşilyurt Dirican, ZEYNEP E. Et Al. "Investigating the effects of empagliflozin and linagliptin treatment on the heart of STZ-diabetic rats: Do they affect cardiac miRNAs?." The CVOT Summit 2023 , Munich, Germany, pp.18-19, 2023

Yeşilyurt Dirican, Z. E. Et Al. (2023) . "Investigating the effects of empagliflozin and linagliptin treatment on the heart of STZ-diabetic rats: Do they affect cardiac miRNAs?." The CVOT Summit 2023 , Munich, Germany, pp.18-19.

@conferencepaper{conferencepaper, author={ZEYNEP ELİF YEŞİLYURT DİRİCAN Et Al. }, title={Investigating the effects of empagliflozin and linagliptin treatment on the heart of STZ-diabetic rats: Do they affect cardiac miRNAs?}, congress name={The CVOT Summit 2023 }, city={Munich}, country={Germany}, year={2023}, pages={18-19} }